Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular Degeneration
Written by: Jeremy Lavine, MD, PhD April 2020 Hsu J, Patel SN, Wolfe JD, et al. Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular Degeneration. JAMA Ophthalmol. 2020 Apr 2. doi: 10.1001/jamaophthalmol.2020.0724. [Epub ahead of print] Anti-vascular endothelial growth factor (VEGF) therapy is the gold standard for neovascular age-related macular degeneration (nvAMD). Despite monthly injections, […]